NCT00016185View on ClinicalTrials.gov

Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2001

Primary Completion Date

February 28, 2003

Study Completion Date

December 31, 2005

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

alvocidib

DRUG

docetaxel

Trial Locations (1)

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00016185 - Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter